Unsal V, Oner E, Yildiz R, Mert B
BMC Chem. 2025; 19(1):4.
PMID: 39755645
PMC: 11700471.
DOI: 10.1186/s13065-024-01371-4.
Harigua-Souiai E, Masmoudi O, Makni S, Oualha R, Abdelkrim Y, Hamdi S
J Cheminform. 2024; 16(1):134.
PMID: 39609715
PMC: 11605991.
DOI: 10.1186/s13321-024-00929-7.
Mendez-Lucio O, Nicolaou C, Earnshaw B
Nat Commun. 2024; 15(1):9431.
PMID: 39532853
PMC: 11557931.
DOI: 10.1038/s41467-024-53751-y.
Mollineda-Diogo N, Sifontes-Rodriguez S, Aguirre-Garcia M, Escalona-Montano A, Espinosa-Buitrago T, Mondragon-Flores R
Int J Mol Sci. 2024; 25(19).
PMID: 39408911
PMC: 11477194.
DOI: 10.3390/ijms251910582.
Gaiya D, Muhammad A, Musa J, Auta R, Dadah A, Bello R
In Silico Pharmacol. 2024; 12(2):75.
PMID: 39155972
PMC: 11329488.
DOI: 10.1007/s40203-024-00241-0.
FOCUS on NOD2: Advancing IBD Drug Discovery with a User-Informed Machine Learning Framework.
Choudhary R, Mahadevan R
ACS Med Chem Lett. 2024; 15(7):1057-1070.
PMID: 39015268
PMC: 11247655.
DOI: 10.1021/acsmedchemlett.4c00148.
Ceanothanes Derivatives as Peripheric Anionic Site and Catalytic Active Site Inhibitors of Acetylcholinesterase: Insights for Future Drug Design.
Pastene-Burgos S, Munoz-Nunez E, Quiroz-Carreno S, Pastene-Navarrete E, Espinoza Catalan L, Bustamante L
Int J Mol Sci. 2024; 25(13).
PMID: 39000410
PMC: 11242892.
DOI: 10.3390/ijms25137303.
ADMET-AI: a machine learning ADMET platform for evaluation of large-scale chemical libraries.
Swanson K, Walther P, Leitz J, Mukherjee S, Wu J, Shivnaraine R
Bioinformatics. 2024; 40(7).
PMID: 38913862
PMC: 11226862.
DOI: 10.1093/bioinformatics/btae416.
Metabolism characterization and toxicity of N-hydap, a marine candidate drug for lung cancer therapy by LC-MS method.
Lu J, Liang W, Hu Y, Zhang X, Yu P, Cai M
Nat Prod Bioprospect. 2024; 14(1):33.
PMID: 38771401
PMC: 11109052.
DOI: 10.1007/s13659-024-00455-x.
admetSAR3.0: a comprehensive platform for exploration, prediction and optimization of chemical ADMET properties.
Gu Y, Yu Z, Wang Y, Chen L, Lou C, Yang C
Nucleic Acids Res. 2024; 52(W1):W432-W438.
PMID: 38647076
PMC: 11223829.
DOI: 10.1093/nar/gkae298.
ADMETlab 3.0: an updated comprehensive online ADMET prediction platform enhanced with broader coverage, improved performance, API functionality and decision support.
Fu L, Shi S, Yi J, Wang N, He Y, Wu Z
Nucleic Acids Res. 2024; 52(W1):W422-W431.
PMID: 38572755
PMC: 11223840.
DOI: 10.1093/nar/gkae236.
Machine Learning Empowering Drug Discovery: Applications, Opportunities and Challenges.
Qi X, Zhao Y, Qi Z, Hou S, Chen J
Molecules. 2024; 29(4).
PMID: 38398653
PMC: 10892089.
DOI: 10.3390/molecules29040903.
Exploring azomethine ylides reactivity with acrolein through cycloaddition reaction and computational antiviral activity assessment against hepatitis C virus.
Abdessadak O, Kandwal P, Alaqarbeh M, Tabti K, Sbai A, Ajana M
J Mol Model. 2024; 30(1):23.
PMID: 38177613
DOI: 10.1007/s00894-023-05818-8.
Targeting Cathepsin L in Cancer Management: Leveraging Machine Learning, Structure-Based Virtual Screening, and Molecular Dynamics Studies.
Almalki A, Shafie A, Hazazi A, Banjer H, Bakhuraysah M, Almaghrabi S
Int J Mol Sci. 2023; 24(24).
PMID: 38139037
PMC: 10743089.
DOI: 10.3390/ijms242417208.
Natural compound targeting BDNF V66M variant: insights from in silico docking and molecular analysis.
Sakhawat A, Khan M, Rehman R, Khan S, Shan M, Batool A
AMB Express. 2023; 13(1):134.
PMID: 38015338
PMC: 10684480.
DOI: 10.1186/s13568-023-01640-w.
Antileishmanial activity of 5-nitroindazole derivatives.
Mollineda-Diogo N, Chaviano-Montes de Oca C, Sifontes-Rodriguez S, Espinosa-Buitrago T, Monzote-Fidalgo L, Meneses-Marcel A
Ther Adv Infect Dis. 2023; 10:20499361231208294.
PMID: 37915499
PMC: 10617274.
DOI: 10.1177/20499361231208294.
Study on the Antioxidant Effect of Shikonin-Loaded β-Cyclodextrin Forming Host-Guest Complexes That Prevent Skin from Photoaging.
Yue Y, Fang Y, Jia R, Cao K, Chen X, Xia H
Int J Mol Sci. 2023; 24(20).
PMID: 37894857
PMC: 10607292.
DOI: 10.3390/ijms242015177.
Molecular docking analysis of acetylcholinesterase inhibitors for Alzheimer's disease management.
Hakeem I
Bioinformation. 2023; 19(5):565-570.
PMID: 37886145
PMC: 10599677.
DOI: 10.6026/97320630019565.
Molecular docking analysis of KRAS inhibitors for cancer management.
Hakeem I, Alsharif F, Aljadani M, Fahad Alabbas I, Faqihi M, Aloufi A
Bioinformation. 2023; 19(4):411-416.
PMID: 37822837
PMC: 10563554.
DOI: 10.6026/97320630019411.
In Silico Neuroprotective Effects of Specific Metabolites on Parkinson's Disease Targets.
Garcia P, Huang S, De Castro-Cruz K, Leron R, Tsai P
Int J Mol Sci. 2023; 24(18).
PMID: 37762232
PMC: 10530814.
DOI: 10.3390/ijms241813929.